LIXT (STOCKS)
Lixte Biotechnology Holdings, Inc. Common Stock
$6.799200
+0.609200 (+9.84%)
Prev close: $6.190000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Geordan G. Pursglove
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $116.75M
- Employees
- 4
- P/E (TTM)
- -5.98
- P/B (TTM)
- 9.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2024 (Q4)
|
$-0.27 | $0.00 | +0.0000 | +0.00% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $6.39M |
| Research and Development | $496.84K |
| Other Operating Expenses | $5.89M |
| Operating Income/Loss | -$6.39M |
| Income/Loss From Continuing Operations After Tax | -$7.29M |
| Income/Loss From Continuing Operations Before Tax | -$7.29M |
| Interest Expense, Operating | $9.12K |
| Net Income/Loss | -$7.29M |
| Net Income/Loss Attributable To Noncontrolling Interest | $23.02K |
| Net Income/Loss Attributable To Parent | -$7.31M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.31M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Diluted Earnings Per Share | -$1.14 |
| Diluted Average Shares | 20,820,062 |
| Assets | $10.87M |
| Current Assets | $3.41M |
| Noncurrent Assets | $7.46M |
| Fixed Assets | $6.61M |
| Other Non-current Assets | $850.13K |
| Liabilities | $1.69M |
| Current Liabilities | $1.22M |
| Noncurrent Liabilities | $461.77K |
| Equity | $9.18M |
| Equity Attributable To Noncontrolling Interest | $1.23M |
| Equity Attributable To Parent | $7.95M |
| Liabilities And Equity | $10.87M |
| Net Cash Flow From Operating Activities | -$4.33M |
| Net Cash Flow From Operating Activities, Continuing | -$4.33M |
| Net Cash Flow | -$4.33M |
| Net Cash Flow, Continuing | -$4.33M |
| Comprehensive Income/Loss | -$7.29M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.29M |
| Other Comprehensive Income/Loss | $0.00 |